Standards and Guidelines for the Development of Diagnostic Nomenclatures and Alternatives in Mental Health Research and Practice

Abstract

Diagnostic nomenclatures have been central to mental health research and practice since the turn of the 20th century. In recent years, an increasing number of mental health professionals have proposed that a paradigm shift in diagnosis is inevitable. The Standards and Guidelines for the Development of Diagnostic Nomenclatures and Alternatives in Mental Health Research and Practice are intended to serve as a reference for the development of scientifically sound and ethically principled diagnostic nomenclatures and descriptive alternatives. The Standards and Guidelines are divided into four sections that address the purposes; development; type, content, and structure; and scientific grounding of nomenclatures and alternative systems. They are intended to represent best practice in the classification and description of emotional distress for multidisciplinary mental health professionals.

Keywords

diagnosis diagnostic alternatives DSM nomenclature nosology paradigm shift taxonomy

Get full access to this article

View all access options for this article.

References

Agency for Healthcare Research and Quality. (2014). Inclusion criteria (for National Guideline Clearinghouse). Retrieved from http://www.guideline.gov/about/inclusion-criteria.aspx

American Medical Association (2001). AMA code of medical ethics. Retrieved from https://www.ama-assn.org/sites/default/files/media-browser/principles-of-medical-ethics.pdf

American Medico-Psychological Association (American Psychiatric Association). (1918). Statistical Manual for the Use of Institutions for the Insane. New York, NY: National Committee for Mental Hygiene of the American Medico-Psychological Association.

American Psychiatric Association. (1952). Diagnostic and statistical manual of mental disorders (1st ed.). Washington, DC: Author.

American Psychiatric Association. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.

American Psychological Association (APA) Presidential Task Force on Evidence-Based Practice (2006). Evidence-based practice in psychology. American Psychologist, 61, 271-285.

American Psychological Association. (2017). Ethical principles of psychologists and code of conduct. Effective date June 1, 2003 with amendments effective June 1, 2010 and January 1, 2017. Washington, DC: Author.

10.

Andreasen

N. C.

(2007). DSM and the death of phenomenology in America: An example of unintended consequences. Schizophrenia Bulletin, 33, 108-112.

11.

Als-Nielsen

Chen

Gluud

Kjaergard

(2003). Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA Journal of the American Medical Association, 290, 921-928.

12.

Blashfield

R. K.

Keeley

J. W.

Flanagan

E. H.

Miles

S. R.

(2014). The cycle of classification: DSM-I through DSM-5. Annual Review of Clinical Psychology, 10, 25-51.

13.

Boyd

J. H.

Burke

J. D.

Gruenberg

Holzer

C. E.

Rae

D. S.

George

L. K.

. . . Nestadt

(1984). Exclusion criteria of DSM-III: A study of co-occurrence of hierarchy-free syndromes. Archives of General Psychiatry, 41, 983-989.

14.

British Psychological Society. (2014). Understanding psychosis and schizophrenia. Retrieved from https://www.bps.org.uk/system/files/user-files/Division%20of%20Clinical%20Psychology/public/understanding_psychosis_-_final_19th_nov_2014.pdf

15.

Cain

D. M.

Lowenstein

Moore

D. A.

(2005). The dirt on coming clean: Perverse effects of disclosing conflicts of interest. Journal of Legal Studies, 31, 1-25.

16.

Cerullo

(2010). The end of the DSM? Bulletin of the Association for the Advancement of Philosophy and Psychiatry, 17, 2-3.

17.

Choudhry

N. K.

Stelfox

H. T.

Detsky

A. S.

(2002). Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA Journal of the American Medical Association, 287, 612-617.

18.

Cosgrove

Krimsky

(2012). A comparison of DSM-IV and DSM-5 panel members’ financial associations with industry: A pernicious problem persists. PLoS Medicine, 9, e1001190. doi:10.1371/journal.pmed.1001190

19.

Clark

Barbour

Norton

Simpson

Veitch

(2012). Does conflict of interest disclosure worsen bias? PLoS Medicine, 9, e10011210. doi:10.1371/journal.pmed.1001210

20.

Davidson

Stayner

(1997). Loss, loneliness, and the desire for love: Perspectives on the social lives of people with schizophrenia. Psychiatric Rehabilitation Journal, 20, 3-12.

21.

Feighner

J. P.

Robins

Guze

S. B.

Woodruff

R. A.

Winokur

Munoz

(1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57-63.

22.

Flanagan

E. H.

Davidson

Strauss

J. S.

(2010). The need for patient-subjective data in the DSM and the ICD. Psychiatry, 73, 297-307.

23.

Flanagan

E. H.

Keeley

Blashfield

R. K.

(2008). An alternative hierarchical organization of the mental disorders of the DSM-IV. Journal of Abnormal Psychology, 117, 693-698.

24.

Flanagan

E. H.

Solomon

L. A.

Johnson

Ridgway

Strauss

J. S.

Davidson

(2012). Considering DSM-5: The personal experience of schizophrenia in relation to the DSM-IV-TR criteria. Psychiatry, 75, 375-386.

25.

Frances

A. J.

Egger

H. L.

(1999). Whither psychiatric diagnosis. Australian and New Zealand Journal of Psychiatry, 33, 161-165.

26.

Fulford

K. W. M.

Thornton

Graham

(Ed.). (2006). Oxford textbook of philosophy and psychiatry. Oxford, England: Oxford University Press.

27.

Genuis

S. J.

(2005). The proliferation of clinical practice guidelines: Professional development or medicine-by-numbers? Journal of American Board of Family Practice, 18, 419-425.

28.

Gottesman

I. I.

Gould

T. D.

(2003). The endophenotype concept in psychiatry: Etymology and strategic intentions. American Journal of Psychiatry, 160, 636-645.

29.

Grilli

Magrini

Penna

Giorgio

Liberati

(2000). Practice guidelines developed by specialty societies: The need for a critical appraisal. Lancet, 355, 103-106.

30.

Grob

G. N.

(1991). Origins of DSM-I: A study in appearance and reality. American Journal of Psychiatry, 148, 421-431.

31.

Haslam

(2002). Kinds of kinds: A conceptual taxonomy of psychiatric categories. Philosophy, Psychiatry, & Psychology, 9, 203-217.

32.

Haslam

(2014). Natural kinds in psychiatry: Conceptually implausible, empirically questionable, and stigmatizing. In Kincaid

Sullivan

J.A.

(Eds.), Classifying Psychopathology (pp. 11-28). Cambridge, MA: MIT Press.

33.

B-C.

Andreasen

N. C.

Ziebell

Pierson

Magnotta

(2011). Long-term antipsychotic treatment and brain volumes. Archives of General Psychiatry, 68, 128-137.

34.

Hearing Voices Network (2013). Position statement on DSM-5 & psychiatric diagnosis. Retrieved from http://www.hearing-voices.org/wp-content/uploads/2013/05/HVN-Position-Statement-on-DSM5-and-Diagnoses.pdf

35.

Institute of Medicine. (2009). Conflict of interest in medical research, education, and practice. Washington, DC: National Academies Press.

36.

Institute of Medicine. (2011). Clinical practice guidelines we can trust. Washington, DC: National Academies Press.

37.

Insel

(2013, April 29). Transforming diagnosis [Web log post]. Retrieved from http://www.nimh.nih.gov/about/director/2013/transforming-diagnosis.shtml

38.

Insel

T. H.

Cuthbert

B. N.

(2009). Endophenotypes: Bridging genomic complexity and disorder heterogeneity [Commentary]. Biological Psychiatry, 66, 988-989.

39.

Insel

T. R.

Lieberman

J. A.

(2013, May). DSM-5 and RDoC: shared interests [Press release]. National Institute of Mental Health. Retrieved from https://www.nimh.nih.gov/news/science-news/2013/dsm-5-and-rdoc-shared-interests.shtml?utm_source=rss_readers&utm_medium=rss&utm_campaign=rss_summary

40.

International Commission on Zoological Nomenclature. (2000). The international code of zoological nomenclature, fourth edition. Retrieved from http://iczn.org/iczn/index.jsp

41.

International Association for Plant Taxonomy. (2011). International code of nomenclature for algae, fungi, and plans (Melbourne code). Retrieved from http://www.iapt-taxon.org/nomen/main.php

42.

Johnstone

Dallos

(Eds.). (2006). Formulation in psychology and psychotherapy: Making sense of people’s problems (2nd ed.). New York, NY: Routledge.

43.

Keeley

J. W.

Morton

H. E.

Blashfield

R. K.

(2014). Classification. In Blaney

P. H.

Krueger

R. F.

Millon

(Eds.), Oxford textbook of psychopathology (3rd ed., pp. 42-70). New York, NY: Oxford University Press.

44.

Kendell

Jablensky

(2003). Distinguishing between the validity and utility of psychiatric diagnoses. American Journal of Psychiatry, 160, 4-12.

45.

Kendler

K. S.

(2013). What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Molecular Psychiatry, 18, 1058-1066.

46.

Kessler

R. C.

Berglund

Demler

Robert

Merikangas

K. R.

Walters

E. E.

(2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62, 593-602.

47.

Kessler

R. C.

McGonagle

K. A.

Zhao

Nelson

C. B.

(1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Study. Archives of General Psychiatry, 51(1), 8-19.

48.

Kotov

Krueger

R. F.

Watson

Achenbach

T. M.

Althoff

R. R.

Bagby

R. M.

. . . Zimmerman

(2017). The hierarchical taxonomy of psychopathology (HiTOP): A dimensional alternative to traditional nosologies. Journal of Abnormal Psychology, 126, 454-477.

49.

Krueger

R. F.

Markon

K. E.

(2006). Reinterpreting comorbidity: A model-based approach to understanding and classifying psychopathology. Annual Review of Clinical Psychology, 2, 111-133.

50.

Krimsky

(2012). Do financial conflicts of interest bias research? An inquiry into the “funding effect” hypothesis. Science, Technology, & Human Values, 38(4), 566-587.

51.

Kroska

Harkness

S. K.

(2008). Exploring the role of diagnosis in the modified labeling theory of mental health. Department of Sociology, 71, 193-208.

52.

Kuhn

T. S.

(1996). The structure of scientific revolutions (3rd ed.). Chicago, IL: University of Chicago Press. (Original work published 1962)

53.

Kupfer

D. F.

First

M. B.

Regier

D. A.

(Eds.). (2002). A research agenda for DSM-V. Washington, DC: American Psychiatric Association.

54.

Larivaara

Kiuttu

Taanila

(2001). The patient centered interview: The key to biopsychosocial diagnosis and treatment. Scandinavian Journal of Primary Health Care, 19, 8-13.

55.

Lehman

A. F.

Ward

N. C.

Linn

L. S.

(1982). Chronic mental patients: The quality of life issue. American Journal of Psychiatry, 139, 1271-1276.

56.

Link

B. G.

Phelan

J. C.

(1999). The labeling theory of mental disorder (II): The consequences of labeling. In Horwitz

A. V.

Scheid

T. L.

(Eds.), A handbook for the study of mental health: social contexts, theories, and systems (pp. 361-376). New York, NY: Cambridge University Press.

57.

Matheson

(2008). Corporate science and the husbandry of scientific and medical knowledge by the pharmaceutical industry. Bio Societies, 3, 355-382.

58.

Mayes

Horwitz

(2005). DSM-III and the revolution in the classification of mental illness. Journal of the History of the Behavioral Sciences, 41, 249-267.

59.

Moher

Liberati

Tetzlaff

Altman

D. G.

(2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Journal of Clinical Epidemiology, 151, 264-269. doi:10.1016/j.jclinepi.2009.06.005

60.

Moskvina

Craddock

Holmans

Nikolov

Pahwa

J. S.

Green

. . . O’Donovan

M. C.

(2009). Gene-wide analyses of genome-wide association data sets: Evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Molecular Psychiatry, 14, 252-260.

61.

National Institute of Mental Health (NIMH) (2015). Data sharing expectations for clinical research funded by NIMH. Retrieved from https://grants.nih.gov/grants/guide/notice-files/NOT-MH-15-012.html

62.

Parnas

Zahavi

(2002). The role of phenomenology in psychiatric diagnosis and classification. In Maj

Gaebel

Lopez-Ibor

J. J.

Sartorius

(Eds.), Psychiatric diagnosis and classification (pp. 137-162). Chichester, England: John Wiley.

63.

Plato. (1952). Phaedrus ( Hackforth

, Ed.). New York, NY: Cambridge University Press. (Original work composed 370 B.C.)

64.

Raskin

J. D.

Gayle

M. C.

(2014, August). Do psychologists want an alternative to the DSM-5? In Robbins

B. D.

(Chair), DSM-5—Problems, solutions, and alternatives. Symposium presented at the 122nd Annual Convention of the American Psychological Association, Washington, DC.

65.

Reed

G. M.

Roberts

M. C.

Keeley

Hooppell

Matsumoto

Sharan

. . . Medina-Mora

M. E.

(2013). Mental health professionals’ natural taxonomies of mental disorders: implications for the clinical utility of the ICD-11 and the DSM-5. Journal of Clinical Psychology, 69, 1191-1192.

66.

Regier

D. A.

Narrow

W. E.

Kuhl

E. A.

Kupfer

D. J.

(2009). The conceptual development of the DSM-V. American Journal of Psychiatry, 166, 645-650.

67.

Rose

Wykes

Leese

Bindman

Fleischmann

(2003). Patients’ perspectives on electroconvulsive therapy: Systematic review. BMJ British Medical Journal, 326, 1363-1365.

68.

Sadler

J. Z.

(2005). Values and psychiatric diagnosis. New York, NY: Oxford University Press.

69.

Spitzer

R. L.

Endicott

Robins

(1978). Research diagnostic criteria: Rationale and reliability. Archives of General Psychiatry, 35, 773-782.

70.

Spitzer

R. L.

Forman

J. B.

Nee

(1979). DSM-III field trials: I. Initial interrater diagnostic reliability. American Journal of Psychiatry, 136, 815-817.

71.

Thompson

D. F.

(1993). Understanding financial conflicts of interest. New England Journal of Medicine, 329, 573-576.

72.

Wakefield

J. C.

(2013). The DSM-5 debate over the bereavement exclusion: Psychiatric diagnosis and the future of empirically supported treatment. Clinical Psychology Review, 33, 825-845.

73.

Whitaker

(2010). Anatomy of an epidemic. New York, NY: Crown.

74.

Woods

Jones

Bernini

Callard

Alderson-Day

Badcock

J. C.

. . . Krueger

(2014). Interdisciplinary approaches to the phenomenology of auditory verbal hallucinations. Schizophrenia Bulletin, 40(Suppl. 4), S246-S254.

75.

Woods

Jones

Alderson-Day

Callard

Fernyhough

(2015). Experiences of hearing voices: Analysis of a novel phenomenological survey. Lancet Psychiatry, 2, 323-331.

76.

World Health Organization (1949). Manual of the international statistical classification of diseases, injuries, and causes of death. Sixth revision. Geneva, Switzerland: Author.

77.

World Health Organization. (1967). Manual of the international statistical classification of diseases, injuries, and causes of death. Based on recommendations of the eighth revision conference, 1965, and adopted by the nineteenth World Health Assembly. Geneva, Switzerland: Author.

78.

World Health Organization. (1993a). The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: Author. Retrieved from http://www.who.int/classifications/icd/en/bluebook.pdf

79.

World Health Organization. (1993b). The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. Geneva, Switzerland: Author. Retrieved from http://www.who.int/classifications/icd/en/GRNBOOK.pdf

80.

World Health Organization. (2010). International classification of diseases and related health problems–10th Revision. Geneva, Switzerland: Author. Retrieved from http://apps.who.int/classifications/icd10/browse/2010/en. (Original work endorsed 1990)

81.

World Health Organization (2017, October). The 11th Revision of the International Classification of Diseases (ICD-11) is due by 2018! ICD-11 Revision Quarterly Newsletter. World Health Organization. Retrieved from http://www.who.int/classifications/icd/revision/en/